Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.60 -0.07 (-2.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) EBIT Margin (2016 - 2024)

Updated

Kiora Pharmaceuticals (KPRX) posted EBIT Margin of 28.15% for FY2024.

Analysis

Kiora Pharmaceuticals (KPRX) EBIT Margin (2016 - 2024) Analysis & Trends

Since FY2016, Kiora Pharmaceuticals has reported EBIT Margin for 6 years.

  • Annual EBIT Margin shows a five-year change of +288.80 percentage points (FY2019 to FY2024).
  • The FY2024 figure stands as the highest annual EBIT Margin in data going back to FY2016.
  • Business Quant data shows KPRX's EBIT Margin at -56960.51% in FY2020 (-56699.86 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Kiora Pharmaceuticals 16.49 Mn 16.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -12,724.44%
Mar 31, 2024 82.64%
Dec 31, 2020 -9,698.80%
Mar 31, 2019 30.85%
Sep 30, 2018 -1,010.45%
Jun 30, 2018 -1,156.27%
Mar 31, 2018 -217.06%
Sep 30, 2017 -5,542.60%
Jun 30, 2017 -2,243.44%
Mar 31, 2017 -1,582.17%
Sep 30, 2016 -1,231.17%
Jun 30, 2016 -1,630.90%
API Access

Kiora Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=KPRX&period=max&api_key=YOUR_API_KEY